Articles: Determinants of genital human papillomavirus infection in young women

Journal of the National Cancer Institute

Volumn 83, Issue 14, 1991, Pages 997-1003

  Ley, Catherine ^a   Bauer, Heidi M ^b   Reingold, Arthur ^a   Schiffman, Mark H ^c   Chambers, Janet C ^a   Tashiro, Cathy J ^a   Manos, M Michele ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; FEMALE GENITAL SYSTEM; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VIRUS INFECTION; WART VIRUS;

AGE DISTRIBUTION; AGE FACTORS; BEHAVIOR; BIOLOGY; BLACKS; CANCER; CERVICAL CANCER--ETIOLOGY; CONTRACEPTION; CONTRACEPTIVE USAGE; CULTURAL BACKGROUND; DATA ANALYSIS; DEMOGRAPHIC FACTORS; DISEASES; ETHNIC GROUPS; EXAMINATIONS AND DIAGNOSES; FAMILY PLANNING; INFECTIONS; LABORATORY EXAMINATIONS AND DIAGNOSES; LITERATURE REVIEW; MARITAL STATUS; MEASUREMENT; MULTIPLE PARTNERS; NEOPLASMS; NUPTIALITY; PELVIC INFECTIONS--DETERMINANTS; PELVIC INFECTIONS--TRANSMISSION; POPULATION; POPULATION CHARACTERISTICS; PREVALENCE; REPRODUCTIVE TRACT INFECTIONS; RESEARCH METHODOLOGY; RISK FACTORS; SEX BEHAVIOR; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES; SMOKING;

ADOLESCENT; ADULT; AGE FACTORS; CALIFORNIA; CERVIX NEOPLASMS; CONTRACEPTIVES, ORAL; FEMALE; GENITAL DISEASES, FEMALE; HUMAN; MIDDLE AGE; PAPILLOMAVIRUS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; SEX BEHAVIOR; SEXUALLY TRANSMITTED DISEASES, VIRAL; TUMOR VIRUS INFECTIONS;

EID: 0025912461     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/83.14.997     Document Type: Article

References (46)

1. Parkin DM, Laara E, Muir CS: Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41:184-197, 1988
2. Terris M, Wilson F, Smith H, et al; Epidemiology of cancer of the cervix. V. The relationship of coitus to carcinoma of the cervix. Am J Public Health Nations Health 57:840-847, 1967
3. Brinton LA, Hamman RF, Huggins GR, et al Sexual and reproductive risk factors for invasive squamous cell cervical cancer. JNCI 79:23-30, 1987
4. Devesa SS, Young JL Jr, Brinton LA, et al. Recent trends in cervix uteri cancer. Cancer 64:2184-2190, 1989
5. Jones CJ, Brinton LA, Hamman RF, et al: Risk factors for in situ cervical cancer Results from a case-control study. Cancer Res 50:3657-3662, 1990
6. Winkelstein W Jr: Smoking and cervical cancer—current status: A review. Am J Epidemiol 131:945-957, 1990
7. Verreault R, Chu J, Mandelson M, et al. A case-control study of diet and invasive cervical cancer. Int J Cancer 43:1050-1054, 1989
8. Brinton LA, Reeves WC, Brenes MM, et al: Parity as a risk factor for cervical cancer. Am J Epidemiol 130:486-496, 1989
9. Vessey MP, Lawless M, McPherson K, et al: Neoplasia of the cervix uteri and contraception: A possible adverse effect of the pill. Lancet 2:930-934,1983
10. World Health Organization- WHO collaborative study of neoplasia and steroid contraceptives: Invasive cervical cancer and combined oral contraceptives. Br Med J 290:961-965, 1985
11. Brinton LA, Huggins GR, Lehman HF, et al: Long-term use of oral contraceptives and risk of invasive cervical cancer. Int J Cancer 38:339-344, 1986
12. Slattery ML, Overall JC Jr, Abbott TM, et al: Sexual activity, contraception, genital infections, and cervical cancer Support for a sexually transmitted disease hypothesis. Am J Epidemiol 130:248-258,1989
13. Koutsky LA, Galloway DA, Holmes KK: Epidemiology of genital human papillomavirus infection. Epidemiol Rev 10:122-163, 1988
14. De Villiers EM, Wagner D, Schneider A, et al: Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet 2:703-706,1987
15. Meanwell CA, Cox MF, Blackledge G, et al. HPV 16 DNA in normal and malignant cervical epithelium: Implications for the aetiology and behaviour of cervical neoplasia. Lancet 1:703-707,1987
16. Kiviat NB, Koutsky LA, Paavonen JA, et al: Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic. J Infect Dis 159:293-302, 1989
17. Reeves WC, Brinton LA, Garcia M, et al. Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med 320:1437-1441, 1989
18. Villa LL, Franco EL: Epidemiologic correlates of cervical neoplasia and risk of human papillomavirus infection in asymptomatic women in Brazil. J Natl Cancer Inst 81:332-340, 1989
19. Azocar J, Abad SM, Acosta H, et al: Prevalence of cervical dysplasia and HPV infection according to sexual behavior. Int J Cancer 45:622-625, 1990
20. Kjaer SK, Engholm G, Teisen C, et al: Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: A population-based study. Am J Epidemiol 131:669-682, 1990
21. Lorincz AT, Schiffman MH, Jaffurs WJ, et al: Temporal associations of human papillomavirus infection with cervical cytological abnormalities. Am J Obstet Gynecol 162:645-651, 1990
22. Franco EL: The sexually transmitted disease model for cervical cancer: Incoherent epidemiologic findings and the role of misclassification of human papillomavirus infection. Epidemiology 2:98-104, 1991
23. Cornelissen MT, van der Velden KJ, Walboomers JM, et al. Evaluation of different DNA-DNA hybridization techniques in detection of HPV 16 DNA in cervical smears and biopsies. J Med Virol 25:105-114, 1988
24. Lorincz AT: Human papillomavirus detection tests. In Sexually Transmitted Diseases (Holmes K, et al, eds), 2nd ed. New York: McGraw-Hill, 1989, pp 953-959
25. Bauer HM, Ting Y, Greer CE, et al. Genital HPV infection in female university students as determined by a PCR-based method. JAMA 265:472-477,1991
26. Brandsma J, Burk R, Lancaster W, et al: Interlaboratory variation as an explanation for varying prevalence estimates of human papillomavirus infection. Int J Cancer 43:260-262, 1989
27. Vermund SH, Schiffman MH, Goldberg GL, et al. Molecular diagnosis of genital human papillomavirus infection: Comparison of two methods used to collect exfoliated cervical cells in the genital tract. Am J Obstet Gynecol 160:304-308,1989
28. Manos MM, Wright DK, Lewis AJ, et al: The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In Cancer Cells. Molecular Diagnostics of Human Cancer (Furth M, Greaves M, eds), vol 7. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1989, pp 215-218
29. Schiffman M, Bauer HM, Lorincz AT, et al: A comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J Clin Microbiol 29:573-577, 1991
30. Rothman KJ: Modem Epidemiology. Boston: Little Brown, 1986
31. Franceschi S, Doll R, Gallwey J, et al: Genital warts and cervical neoplasia: An epidemiological study. Br J Cancer 48:621-628, 1983
32. Daling JR, Sherman KJ, Weiss NS: Risk factors for condyloma acuminatum in women. SexTransm Dis 13:16-18, 1986
33. Rosenfeld WD, Vermund SH, Wentz SJ, et al: High prevalence rate of human papillomavirus infection and association with abnormal papanicolaou smears in sexually active adolescents. Am J Dis Child 143:1443-1447, 1989
34. Moscicki AB, Palefsky J, Gonzales J, et al. Human papillomavirus infection in sexually active adolescent females: Prevalence and risk factors. Pediatr Res 28:507-513, 1990
35. Oriel JD: Natural history of genital warts. Br J Vener Dis 17:1-13, 1971
36. Becker TM, Stone KM, Alexander ER: Genital human papillomavirus infection: A growing concern. Obstet Gynecol Clin North Am 14:389-396, 1987
37. Hildesheim A, Reeves WC, Brinton LA, et al: Association of oral contraceptive use and human papillomaviruses in invasive cervical cancers. Int J Cancer 45:860-864, 1990
38. Negrini BP, Schiffman MH, Kurman RJ, et al: Oral contraceptive use, human papillomavirus infection, and risk of early cytologic abnormalities of the cervix. Cancer Res 50:4670-4675,1990
39. Irwin KL, Rosero-Bixby L, Oberle MW, et al. Oral contraceptives and cervical cancer risk in Costa Rica: Detection bias or causal association? JAMA 259:59-64, 1988
40. Pater MM, Hughes GA, Hyslop DE, et al: Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papil-lomavirus DNA. Nature 335:832-835, 1988
41. Chan WK, Klock G, Bernard HU: Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J Virol 63:3261-3269, 1989
42. Wright NH, Vessey MP, Kenward B, et al: Neoplasia and dysplasia of the cervix uteri and contraception: A possible protective effect of the diaphragm. Br J Cancer 38:273-279, 1978
43. Celentano DD, Klassen AC, Weisman CS. et al: The role of contraceptive use in cervical cancer: The Maryland Cervical Cancer Case-Control Study. Am J Epidemiol 126:592-604,1987
44. Brinton LA, Schairer C, Haenszel W, et al: Cigarette smoking and invasive cervical cancer. JAMA 255:3265-3269, 1986
45. Herrero R, Brinton LA, Reeves WC, et al: Invasive cervical cancer and smoking in Latin America. J Natl Cancer Inst 81:205-211.1989
46. Brisson J, Roy M, Fortier M, et al Condyloma and intraepithelial neoplasia of the uterine cervix: A case-control study. Am J Epidemiol 128:337-342,1988